Early diagnosis is critical, as every 30-minute delay between symptoms and treatment increases the 1-year mortality rate by 7.5%.1
TnT Gen 5 STAT, an assay that aids in the diagnosis of myocardial infarction, has a negative predictive value of over 99% in just 3 hours which provides you the confidence to rule patients in - and out - faster.2,3
References: Troponin T Gen 5 STAT package insert 2017 , Siemens ADVIA Centaur and ATELLICA hsTnI package inserts 2018 (on file), Beckman Access and DxI hsTnI package inserts 2018 (on file), Abbott Architext hsTnI package insert (on file)
* TnT Gen 5 satisfies the high sensitivity criteria on the cobas e 601 and e 602
TnT Gen 5 STAT is the FIRST highly sensitive troponin in US history.2,4
TnT Gen 5 STAT is the first FDA-cleared troponin assay to meet the IFCC recommendations4 for high sensitivity5 AND deliver optimal precision per the Fourth Universal Definition of Myocardial Infarction.6
TnT Gen 5 STAT provides clear advantages over other high sensitive troponin assays 2, 4, 8, 9, 10
View Full TableTnT Gen 5 STAT provides clear advantages over other high sensitive troponin assays 2, 4, 8, 9, 10
|
99th Percentile |
Time to result |
Triage after two serial draws |
Standardized Sex Specific Cutoffs |
Global Launch Date |
US Launch Date |
Peer-reviewed articles |
|---|---|---|---|---|---|---|---|
Roche TnT Gen 5 STAT |
19 ng/L |
9 min. |
YES |
YES |
2009 |
2017 |
>1500 |
Siemens ADVIA Centaur and ATELLICA hsTnI |
Not standardized |
18/10 min. Not standardized |
NO |
NO |
2017 |
2018 |
<50 |
Beckman Access and DxI hsTnI |
Not standardized |
17 min. |
YES |
NO |
2018 |
2018 |
<50 |
| Abbott Architect hsTnI | N/A | 17 min. | YES | N/A | 2013 | 2019 | >200 |
Ortho hsTnI |
None available |
||||||
With TnT Gen 5 STAT, you’re backed by the most comprehensive educational offering in the industry:
Learn about evidence-based best practices and current care guidelines from cardiac subject matter experts.
Access insights and peer-to-peer support from the first adopters of TnT Gen 5 STAT.
Receive dedicated before-and-after sales support from our highly experienced, specialized teams.
References:
1. De Luca G., Suryapranata, H., Ottervanger, J.P., and Antman, E.M. (2004). Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction. Circulation 109:1223–1225.
2. Elecsys TnT Gen 5 STAT Package Insert, 2017.
3. As compared to previous generation troponin assays
4. TnT Gen 5 satisfies the IFCC high sensitivity criteria on the cobas e 601 and e 602
5. https://www.aacc.org/publications/cln/cln-stat/2015/april/16/new-guidance-on-high-sensitivity-cardiac-troponin-testing (Accessed 4/27/18)
6. https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2018/08/24/00/09/fourth-universal-definition-of-mi-esc-2018 (Accessed 10/30/2018)
7. Tobias Reichlin, M.D., et al. (2009). Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays. N Engel J Med 361:858-867. DOI: 10.1056/NEJMoa0900428
8. Siemens ADVIA Centaur and ATELLICA hsTnI package inserts 2018 (on file)
9. Beckman Access and DxI hsTnI package inserts 2018 (on file)
10. Abbott Architect hsTnI package insert 2019 (on file)
